Hip Girdle Muscle Activation by Whole-Body Vibration to Achieve the Impact of Walking and Running: A Prospective Pilot Study in Healthy Children.

Surface electromyography was recorded for four hip girdle muscles during WBVT at multiple amplitude and frequency combinations in healthy children.

• A prospective pilot study involving 20 healthy children was conducted.
• Muscles evaluated included the gluteus medius, tensor fascia lata, iliopsoas, and rectus femoris.
• WBVT was tested at amplitudes of 1, 2, and 3 mm and frequencies of 5–20 Hz.
• Steady-state 10-second epochs were extracted for analysis.
• Muscle activation during WBVT was compared against activation during walking and running trials.

WBVT produced short-term increases in hip-girdle muscle activation under tolerable conditions.

• WBVT-induced activation exceeded the RMS values observed during walking or running at specified vibration settings.
• The reported thresholds indicate vibration settings at which WBVT-induced activation exceeded walking or running RMS values, rather than indicating significant within-WBVT frequency differences.
• Dose-response analyses showed no statistically significant increases in activation beyond 10 Hz within WBVT conditions.
• Results are described as providing hypothesis-generating insights rather than being indicative of therapeutic benefit.

The 3 mm/10 Hz WBVT setting was identified as optimal for achieving hip girdle muscle activation comparable to walking or running.

• The optimal setting was defined as the highest activation within tolerable ranges.
• The 3 mm/10 Hz setting met the criteria of replicating effects of walking or running without causing discomfort.
• No statistically significant increases in activation were observed beyond 10 Hz within WBVT conditions.
• Tolerability was a key criterion in defining the optimal setting alongside muscle activation levels.

The study was designed as a prospective pilot study and its findings are hypothesis-generating rather than confirmatory of therapeutic benefit.

• The authors explicitly state the data are 'not indicative of therapeutic benefit.'
• The study involved 20 healthy children, limiting generalizability to clinical populations.
• The authors note the data 'provide hypothesis-generating insights for future clinical studies involving children with movement limitations.'
• The study was characterized as a pilot study, indicating preliminary scope and sample size.